Differential gene expression and functional analysis implicate novel mechanisms in enteric nervous system precursor migration and neuritogenesis  by Vohra, Bhupinder P.S. et al.
98 (2006) 259–271
www.elsevier.com/locate/ydbioDevelopmental Biology 2Differential gene expression and functional analysis implicate
novel mechanisms in enteric nervous system precursor
migration and neuritogenesis
Bhupinder P.S. Vohra a, Keiji Tsuji b,c, Mayumi Nagashimada b,d, Toshihiro Uesaka b,
Daniel Wind a, Ming Fu a, Jennifer Armon a, Hideki Enomoto b,⁎, Robert O. Heuckeroth a,⁎
a Department of Pediatrics and Department of Molecular Biology and Pharmacology, Washington University School of Medicine,
660 S. Euclid Avenue, Box 8208, St. Louis, MO 63110, USA
b Laboratory for Neuronal Differentiation and Regeneration, RIKEN Center for Developmental Biology, 2-2-3 Minatojima-minamimachi,
Chuo-ku, Kobe, Hyogo 650-0047, Japan
c Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kamigyo-ku, Kyoto 602-8566, Japan
d Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
Received for publication 17 April 2006; revised 17 May 2006; accepted 22 June 2006
Available online 27 June 2006Abstract
Enteric nervous system (ENS) development requires complex interactions between migrating neural-crest-derived cells and the intestinal
microenvironment. Although some molecules influencing ENS development are known, many aspects remain poorly understood. To identify
additional molecules critical for ENS development, we used DNA microarray, quantitative real-time PCR and in situ hybridization to compare
gene expression in E14 and P0 aganglionic or wild type mouse intestine. Eighty-three genes were identified with at least two-fold higher
expression in wild type than aganglionic bowel. ENS expression was verified for 39 of 42 selected genes by in situ hybridization. Additionally,
nine identified genes had higher levels in aganglionic bowel than in WT animals suggesting that intestinal innervation may influence gene
expression in adjacent cells. Strikingly, many synaptic function genes were expressed at E14, a time when the ENS is not needed for survival. To
test for developmental roles for these genes, we used pharmacologic inhibitors of Snap25 or vesicle-associated membrane protein (VAMP)/
synaptobrevin and found reduced neural-crest-derived cell migration and decreased neurite extension from ENS precursors. These results provide
an extensive set of ENS biomarkers, demonstrate a role for SNARE proteins in ENS development and highlight additional candidate genes that
could modify Hirschsprung's disease penetrance.
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doi:10.1016/j.ydbio.2006.06.033multipotent neural crest cells (Gariepy, 2004; Gershon, 1997;
Grundy and Schemann, 2005). As these cells migrate through
the intestinal environment, they actively proliferate before
differentiating into all of the different types of neurons and
glia that populate the ENS. Once established, the ENS controls
intestinal motility, regulates intestinal secretion, responds to
sensory stimuli from the bowel wall and controls intestinal blood
flow.
A small number of genes are now known to influence specific
aspects of ENS development (Gariepy, 2004; Gershon, 1997;
Grundy and Schemann, 2005; Newgreen and Young, 2002a,b;
Taraviras and Pachnis, 1999), but they are not sufficient to
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the ENS. In particular, the molecular mechanisms that control
ENS precursor migration and neurite extension remain poorly
understood. One major barrier to progress in ENS biology is
inadequate information about gene expression within the ENS
and in the gut wall. Therefore, in this report, we have used DNA
microarray analysis and quantitative real-time polymerase chain
reaction (qRT-PCR) to compare gene expression in normally
innervated and aganglionic small bowel from E14 and newborn
mice with Ret or Gfrα1 deficiency. These differential gene
expression studies led to the identification of many genes
expressed more strongly in the ENS than in surrounding cells,
including a number of genes with a potential role in ENS
precursor migration, neurite extension, cell adhesion and
transcription. Additional genes with intestinal epithelial expres-
sion were dysregulated in the Ret−/− bowel.
From the identified genes, we were particularly interested in
pursuing functional studies of molecules that might control cell
migration or neurite extension. These studies are important
since failure of ENS precursor migration causes distal intestinal
aganglionosis (Hirschsprung's disease) and extension of
neurites from these ENS precursors is essential for forming an
interconnected plexus of cells that controls intestinal function.
Both of these processes also require complex changes in the
cytoskeleton and the addition of membrane to the leading edge
of the migrating cell or growing neurite (Park et al., 2002b;
Pfenninger et al., 2003; Schmoranzer et al., 2003; Zakharenko
and Popov, 1998). We were intrigued by the observation that
every component of the synaptic machinery we investigated
was present in the ENS at E14. While these proteins could help
refine synaptic connections, we hypothesized instead that they
might have a role in neurite extension or ENS precursor
migration. This hypothesis was based on recent data suggesting
that both SNARE (soluble N-ethylmaleimide-sensitive factor
(NSF) attachment protein (SNAP) receptor) proteins and in
some cases specific neurotransmitters may be important for cell
migration or neurite growth (Pfenninger et al., 2003; Proux-
Gillardeaux et al., 2005; Tayeb et al., 2005). SNAREs in
particular form a large family of proteins that are essential for
intracellular membrane trafficking events requiring membrane
fusion (Ungar and Hughson, 2003). Membrane fusion in turn
may be important at the leading edge of migrating cells or in the
growth cone of neurites to add new membrane to specific
regions of the cell. Both vesicle-associated SNAREs (v-
SNAREs) and their membrane target (t-SNAREs) were found
in the developing ENS at E14.
To test the hypothesis that SNARE-mediated vesicle fusion
was essential for ENS precursor migration or neurite extension,
we used the highly specific proteases Botulinum neurotoxin A
(BoNT/A) (Blasi et al., 1993) to inhibit the t-SNARE Snap25
(synaptosomal-associated protein 25) and Tetanus neurotoxin
(TeNT) (Schiavo et al., 1992) to inhibit the v-SNARE Vamp
(vesicle-associated membrane protein)/synaptobrevin. Both of
these treatments delayed neural-crest-derived cell migration
into the distal bowel and reduced neurite growth in ENS
precursors in vitro. In contrast, these toxins had no effect on cell
survival or proliferation. Together, these observations providean extensive set of genes that are prominently expressed in the
developing ENS, highlight potential Hirschsprung's disease
modifier genes and demonstrate novel roles for SNARE
proteins in ENS development.
Materials and methods
Microarray analysis
RNAwas prepared using TRI reagent (Sigma, St. Louis, MO) and purified
by RNeasy mini kit (Qiagen, Hilden, Germany). Probes from three E14 WT and
three Ret−/− littermate mouse bowel segments were hybridized to separate
U74Av2, U74Bv2 and U74Cv2 arrays (2 genotypes×3 mice/genotype×3
different arrays/mouse=18 arrays total, Affymetrix, Santa Clara, CA). These
probes were prepared from whole mouse intestine including esophagus,
stomach, small bowel and colon. In addition, probes prepared from two WT
and two mutant mouse small bowel segments (one Ret−/− and one Gfrα1−/−) at
P0 were also hybridized to four separate U74Av2 arrays. All of the Ret−/− and
Gfrα1−/− mice used for these studies had been bred into a C57BL/6 genetic
background for at least 10 generations. Data were analyzed using Affymetrix
MicroArray Suite 4.0 and GeneChip 3.1 Expression Analysis and Statistical
Algorithms, dChip and Spotfire DecisionSite for functional genomics software.
The complete methodology and full data sets are available at http://
bioinformatics.wustl.edu and at http://www.ncbi.nlm.nih.gov/geo/.
qRT-PCR
Primers designed to generate short amplicons (50–100 bp, Tm about 60°C)
were synthesized by Integrated DNATechnologies Inc (IDT, Coralville, IA) and
are listed in Supplementary Table 1. qRT-PCR was performed in triplicate for
each cDNA with SYBR green PCR Master mix (Applied Biosystems, Foster
City, CA) and the iCycler iQ (Bio-Rad, Hercules, CA). Control reactions were
performed omitting reverse transcriptase from the cDNA synthesis. For each
gene, qRT-PCR was performed with RNA from three individual WT and three
individual aganglionic small bowel segments. The RNA content of samples was
normalized based on GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
amplification. The threshold cycle (CT value) at which a significant increase in
PCR product is first detected was recorded. ΔCT=CT of gene of interest minus
CT of GAPDH. For nine genes, “fold changes” in RNA abundance between WT
and aganglionic bowel were directly determined using standard dilution curves.
For these genes, one cycle change in CT corresponded to a 2.1±0.2 (SEM)
change in RNA dilution. To estimate the magnitude of the difference in
expression for the other individual RNAs, theΔΔCT (=ΔCTWTminusΔCT for
aganglionic bowel) was transformed to “fold change”=2−ΔΔCT.
In situ hybridization
Wild type P0 C57BL/6 mice were perfused with cold 4% paraformaldehyde
(PFA), post-fixed overnight at 4°C and then frozen in OCT before sectioning at
14 μm thickness. Slides were warmed to 25°C, baked 15 min at 50°C and then
fixed again in 4% PFA for 20 min at 25°C. After washing twice in
diethylpyrocarbonate-treated phosphate-buffered saline (PBS-DEPC, 10 mM)
for 5 min, tissues were digested in Proteinase K (25 μg/ml) for 14–19 min in
(50 mM Tris pH 7.5, 5 mM EDTA, DEPC-treated water). Slides were then
washed again in PBS-DEPC (2×5 min), incubated in 4% PFA for (15 min,
25°C) and rinsed in DEPC-treated water. Tissues were then blocked with 0.2%
acetic anhydride/0.1 M triethanolamine (10 min, 25°C), washed in PBS-DEPC
(5 min, 25°C) and pre-hybridized for 3 h at 65°C in pre-hybridization solution
(50% formamide, 5× SSC, 1 mg/ml yeast tRNA, 100 μg/ml Heparin, 1×
Denhardt's Solution, 0.1% Tween 20 (Sigma P-1379), 0.1% CHAPS (Sigma C-
3023), 5 mM EDTA pH 8.0). Riboprobes (2 ng/ml final concentration) were
then added to fresh pre-hybridization solution, slides were covered with
coverslips and tissues were hybridized overnight at 65°C in humidified chamber.
Following hybridization, tissues were washed in 1× SSC/50% formamide at
65°C (3×30 min) then twice in PBT (10 mM PBS with 0.1% Triton X-100 and
2 mg/ml BSA) for 20 min at 25°C and then blocked with PBT/20%NSS (normal
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(overnight, 4°C) with an anti-digoxigenin antibody conjugated to alkaline
phosphatase (Roche, 1:2000) in fresh blocking solution (PBT/20% NSS). Slides
were then washed in PBT (3×30 min, 25°C) followed by washing once in
alkaline phosphatase (AP) buffer (100 mM Tris pH 9.5, 50 mMMgCl2, 100 mM
NaCl, 0.1% Tween 20) with levamisole (5 mM, DakoCytomation) for 5 min and
once in AP buffer without levamisole. Finally, slides were incubated in AP
buffer with 3.5 μl/ml BCIP (0.35% final concentration) and 1.5 μl/ml NBT
(0.15% final concentration) for 1–3 days in dark at 4°C or until desired stain is
attained. Plasmids used to generate most in situ probes are provided in
Supplementary Table 2. For a few genes (Hes6, Hoxb5, Hoxa5, Pcgf1, Metrn,
Tbx3), approximately 300 bp cDNA fragments were isolated by PCR and the
cloned cDNA were used as riboprobe templates. Primers used to isolate these
cDNA are listed at the end of Supplementary Table 1.
Primary culture of immunoselected ENS precursors
Enteric neural crest were immunoselected from E12.5 embryonic CF1
mouse small bowel and colon using p75NTR antibody (Wu et al., 1999). Bowel
was dissociated with collagenase (1 mg/ml) and dispase (1 mg/ml) to yield a
single cell suspension. After p75NTR antibody (#9651, a generous gift of Dr.
Moses Chao (Huber and Chao, 1995), 1:1000, 1 h, 4°C) exposure in B27
(Invitrogen, NY, USA) supplemented Neurobasal medium, cells were incubated
with goat anti-rabbit coupled paramagnetic beads (Miltenyi Biotec GmbH, 1:50,
1 h, 4°C) before separating neural crest cells from unselected cells with a
positive selection column (MACS Separation columns, Miltenyi Biotec GmbH).
Immunoselected neural crest cells were plated at 700 cells/well in poly-D-lysine/
laminin-coated 8-well chamber slides (Biocoat, Fisher) and grown in
Neurobasal medium supplemented with B27 and glial-cell-line-derived
neurotrophic factor (GDNF, 50 ng/ml, PreproTech, Rocky Hill, NJ). For some
experiments, cultures of dissociated E12.5 small bowel cells were treated with
50 ng/ml TeNT (Munro et al., 2001) or 10−7 M BoNT/A (Gerona et al., 2000)
(Sigma, St. Louis) 6 h after plating. After an additional 48 h in culture, cells were
fixed for immunohistochemistry.
Organ culture analysis of neural crest migration
E11.5 CF1 mouse gut explants containing stomach, small bowel and colon
were cultured in 500 μl (DMEM (Dulbecco's Modified Eagle Medium), 10%
fetal calf serum, penicillin/streptomycin) containing 10−7 M BoNT/A, 50 ng/ml
TeNT or vehicle (10 μl PBS) and were pinned to 2% agarose with 4-0 stainless
steel filaments (Ethicon). This method, which is similar in principle to gut organ
culture techniques previously described (Young et al., 1998), preserves the
tubular gut while allowing organ growth and migration of ENS precursors
within the gut wall. After 50 h in a 37°C, 5% CO2 incubator, tissues were fixed
(4% paraformaldehyde, 30 min, 25°C) and then processed for whole-mount
immunohistochemistry using TuJ1 (1:100) or Ret (1:100) antibodies (4°C
overnight).
Immunohistochemistry
After fixation, immunocytochemistry was performed with neuron-specific
beta III tubulin (TuJ1) antibody (Covance, CA, 1:1000, 4°C overnight), goat
anti-Ret antibody (Neuromics Inc., MN, 1:200, at 4°C overnight), rabbit anti-
phospho-Histone-3 (Upstate, 1:500, 4°C, overnight) or Sox2 antibody (Sigma,
St. Louis, MO). Antibody binding was visualized with Alexa Fluor 350, 488 and
594 conjugated anti-goat and anti-rabbit secondary antibodies (Molecular
Probes, 1:500, 25°C, 1 h) and anti-rabbit FITC (fluorescein isothiocyanate)
secondary antibody (Jackson ImmunoResearch, 1:500, 25°C, 2 h). TUNEL
(Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling) assays
were performed as described (Srinivasan et al., 2005).
Whole-mount acetylcholinesterase and NADPH (reduced
nicotinamide adenine dinucleotide phosphate) diaphorase staining
For α-N-catenin−/− and protocadherin 15−/− mice, the gut including the
esophagus, small bowel and colon was opened along the mesenteric border,pinned flat onto Sylgard 184 (Dow Corning; Essex Brownell, Fort Wayne, IN)
plates, fixed 30 min in 4% paraformaldehyde and then dissected to separate the
muscular layer of the bowel (including the myenteric plexus) from the
submucosa. Submucosal neurons in the small bowel and colon were visualized
after acetylcholinesterase staining (Enomoto et al., 1998; Heuckeroth et al.,
1999). Myenteric neurons and nerve fibers in the esophagus, small bowel and
colon were also visualized using NADPH diaphorase staining (Aimi et al., 1993;
Nemeth et al., 2001) by incubating the tissue in 1 mg/ml β-NADPH (Sigma, St.
Louis, MO), 0.1 mg/ml nitroblue tetrazolium (Sigma) and 0.3% Triton X-100 in
0.1 M sodium phosphate buffer (pH 7.4) at 37°C until ENS staining was seen
(approximately 60 min). Specimens were then rinsed in PBS (3×10 min) and
mounted on slides in 50% glycerol.
Results
Differential gene expression analysis in the WT and
aganglionic bowel
The goal of this study was to identify additional genes that
might critically regulate ENS morphogenesis. We initially
used DNA microarray analysis to compare gene expression in
WT and aganglionic (Ret−/−) mouse bowel at E14 using the
full set of Affymetrix U74Av2, U74Bv2 and U74Cv2 arrays
(36,698 probe sets, 18 arrays). Data were filtered to include
genes “present” in WT, at least 1.2-fold more abundant in WT
than aganglionic bowel and P values less than 0.05
(Supplementary Table 3). Four additional U74Av2 arrays
were performed using P0 WT and aganglionic small bowel. To
expand and validate these differential gene expression
analyses, qRT-PCR was then performed to quantitatively
measure P0 small bowel gene expression in three WT and
three aganglionic Ret−/− newborn mice for 217 genes selected
because of their roles in embryonic development and/or
known functions in other parts of the nervous system. Some of
the identified genes were present at below the detection level
for the gene microarrays but readily detected by qRT-PCR.
Together, these studies led to the identification of 71 genes
expressed at two-fold or higher levels (P<0.05) in P0 WT
small bowel compared to aganglionic bowel (Table 1). An
additional 12 genes were identified as at least 2-fold more
abundant in WT than aganglionic bowel at E14 based solely
on microarray data (Table 1). These genes include a variety of
cell adhesion molecules (n=11), protein kinases and phos-
phatases (n=3), proteases and protease inhibitors (n=4),
receptors and ligands (n=6), signal transduction proteins
(n=5), molecules involved in synaptic function (n=7),
structural proteins (n=6), transcription factors (n=22) and
other miscellaneous genes (n=19).
To determine whether the qRT-PCR and gene microarray
expression levels predict preferential gene expression in the
ENS, 35 genes were targeted for in situ hybridization studies
using P0 intestine: each had 2-fold or greater expression in WT
than in mutant small bowel. For the majority of the genes
analyzed (26/35), expression in the bowel wall was restricted
to the region of the ENS (Figs. 1A and B, Table 1). An
additional 7/35 genes had expression in both the region of the
ENS and in other cells of the gut wall. For one of these genes,
Sox2, we directly confirmed ENS expression at P0 using
double label immunohistochemistry (Fig. 2). For 20 of these
Table 1
Genes with higher abundance in innervated bowel than aganglionic bowel
Gene name Accession # Fold Δ E14 P0 Known Comments (effect of mutation or function)
Cell adhesion
Protocadherin 15 (Pcdh15) AK034124 11.3 x KO: Deafness and vestibular dysfunction (Ames waltzer)
Protocadherin alpha 4 (Pcdha4) D86916 7.5 Thought to be involved in specificity of synaptic
connections
Neural cell adhesion molecule 2 (Ncam2) AF001287 4.4 o x Homophilic adhesion molecule, expressed in olfactory
system
Integrin beta 2-like (Itgb2l) AF051367 3.7 Expressed primarily on neutrophils
Protocadherin alpha 10 (Pcdha10) AB008183 3.6 Thought to be involved in specificity of synaptic
connections
Cadherin 6 (Cdh6) D82029 2.8 Expressed in restricted regions of CNS; KO abnormal
kidneys
Cadherin 9 (Cdh9) U69136 2.8
Junction cell adhesion molecule 3 (Jam3) AI850297 2.7 o o
Cadherin 2 (Cdh2) M31131 2.3 o x KO: Abnormal heart, pancreas and CNS morphogenesis
Semaphorin 3e (Sema3e) Z80941 2.3 Role in axon guidance
Immunoglobulin superfamily, member 4A (Igsf4a) AF061260 2.2* Homophilic cell adhesion molecule, regulates synapse
formation
Kinases and phosphatases
Ret proto-oncogene (Ret) X67812 6654.0 x KO: Hirschsprung
Doublecortin (Dcx) AB011678 14.9 x x KO: lissencephaly
Protein tyrosine phosphatase, receptor type O (Ptpro) U37465 3.0
Proteases and inhibitors
Neuroserpin (Serpini1) AJ001700 17.1 x x KO: Familial encephalopathy
(Pcsk1n)a AI841733 4.0 o x Inhibits prohormone convertase 1
(Serpine 2) a X70296 2.5 Influences neurite outgrowth, NMDA receptor function




Fibroblast growth factor 13 (Fgf13) AF020737 21.1 o x Reduces infarct volume in cerebral ischemia model
(Tmeff2) a AB017270 7.8 x x Hippocampal and mesencephalic neuron
survival factor
Fibroblast growth factor 6 (Fgf6) M92416 4.0
Hepatocyte growth factor (Hgf) X72307 2.3 KO: Death in utero, multiple roles
Chemokine (C–C motif) receptor 9 (Ccr9) AJ132336 2.2 Primarily known to be expressed on T-cells
Fibroblast growth factor 5 (Fgf5) M37823 2.0 KO: Long hair growth (Angora mutation)
Signal transduction
Collapsin response mediator protein 1 (Crmp1) AB006714 24.3 o x Role in axon growth and guidance
Dihydropyrimidinase-like 2 (CRMP2) (Dpysl2) X87817 6.0 x x Role in axon growth and guidance
N-myc downstream regulated gene 4 (Ndrg4) AW121600 5.7 o x
Catenin alpha 2 (Catna2) D25282 4.0 x x KO: Cerebellar hypoplasia, abnormal hippocampal
lamination
RAS dexamethasone-induced 1 (Rasd1) AF009246 2.0 Nitric oxide effector protein
Synaptic function
Synaptotagmin 1 (Syt1) D37792 168.9 x x Synaptic vesicle calcium sensor protein
Reticulon 1 (Rtn1) AW123115 128.0 x x Involved in vesicle trafficking
Synaptosomal-associated protein 25 (Snap25) M22012 22.6 x x Synaptic vesicle fusion protein on plasma membrane
Ca2+-dependent activator protein for secretion (Cadps) D86214 13.9 x x Probable role in calcium activated secretion
Synaptosomal-associated protein 91 (Snap91) M83985 9.0 x x Synapse associated protein
Secretogranin III (Scg3) AV328553 3.9 x x Secretory granule component
Syntaxin binding protein 1 (Stxbp1) D45903 2.5 x KO: Paralysis, essential for neurotransmitter secretion
Structural proteins
Stathmin-like 3 (Stmn3) AF069708 21.1 x x Regulates microtubule dynamics
Microtubule-associated protein tau (Mapt) M18775 38.1 Regulates microtubule dynamics
Internexin neuronal intermediate filament protein,
alpha (Ina)
L27220 2.7* Intermediate filament involved in neurite growth
Neurofilament 3, medium (Nef3) AI849905 2.5*
Stathmin-like 2 (Stmn2) AI839868 2.4* Regulates microtubule dynamics
Neurofilament, light polypeptide (Nefl) M55424 2.3*
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Table 1 (continued)
Gene name Accession # Fold Δ E14 P0 Known Comments (effect of mutation or function)
Transcription factors
Paired-like homeobox 2b (Phox2b) Y14493 288.0 x KO: Hirschsprung, congenital central hypoventillation
Achaete–scute complex homolog-like (Ascl1) M95603 108.4 x Esophageal aganglionosis and other ENS anomalies
Distal-less homeobox 2 (Dlx2) M80540 24.8 o x Probably abnormal ENS, regulates neuronal
differentiation
SRY-box containing gene 2 (Sox2) X94127 17.1 o x KO: Anophthalmia, regulates neuronal differentiation
POU domain, class 3, transcription factor 2 (Pou3f2) NM_008899 13.0 x Regulates Schwann cell development
Forkhead box D3 (Foxd3) AF067421 7.0 KO: Embryonic lethality at E6.5 in mouse
Myelin transcription factor 1 (Myt1) AF004294 6.5 x x Regulates oligodendrocyte development
Early growth response 1 (Egr1) AV369921 5.8 o x KO: Defect in late hippocampal LTP and synaptic
plasticity
Distal-less homeobox 1 (Dlx1) U51000 5.8* Regulates neuronal differentiation in cortex and
hippocampus
Cyclin D binding myb-like transcription factor 1 (Dmtf1) U70017 3.6 o o Tumor suppressor, regulates cell cycle
Neurogenic differentiation 1 (Neurod1) U28068 3.5 o x KO: Absent dentate gyrus granule cells, seizure, diabetes
Activating transcription factor 3 (Atf3) U19118 3.5 Induced in response to injury
Paired box gene 4 (Pax4) AB010557 3.4 KO: Absent pancreatic beta and delta cells
Homeo box B5 (Hoxb5) M26283 3.2 x x
Zinc Finger protein 146 (Zfp146) AJ224763 3.1
Growth factor independent 1B (Gfi1b) AF017275 3.0 Primarily expressed in bone marrow and thymus
Homeobox A3 (Hoxa3) Y11717 2.2 Absent thymus, carotid body, abnormal cranial
nerve axons
Neurogenin 2 (Neurog2) Y07621 2.1 KO: Missing subsets of sensory neurons
Homeobox A5 (Hoxa5) Y00208 2.1 KO: Lung, stomach and vertebral defects
Nuclear receptor subfamily 0, group B, member 1 (Nr0b1) U41568 2.0 KO: Adrenal hypoplasia, hypogonadism
Mesenchyme homeobox 2 (Meox2) Z16406 2.0 Regulates muscle development, expressed in smooth
muscle
SRY-box containing gene 8 (Sox8) AW214326 2.0* Synergistic role with Sox10 in the ENS
Miscellaneous
Erythroid differentiation regulator 1 (Erdr1) AI854606 128.0 x Induces hemoglobin synthesis
ELAV-like 4 (Hu antigen D) (Elavl4) D31953 59.7 x x Neuron-specific RNA binding protein
Neuron-specific gene family member 2 (Nsg2) U17259 42.2 o x Present in Golgi apparatus of neurons
Ganglioside-induced differentiation assoc prot (Gdap1) Y17850 22.6 Mutated in Charcot-Marie-Tooth
Synuclein, gamma (Sncg) AF017255 18.4 x x
Growth associated protein 43 (Gap43) AI841303 13.9 x x Involved in neuron pathfinding
Sulfotransferase family 4A, member 1 (Sult4a1) AF059257 12.1 x x Sulfotransferase
Ca2+ channel, voltage-dependent, gamma subunit 2
(Cacng2)
AF077739 10.3 o x KO: Stargazer mouse, absence seizures, ataxia
Ubiquitin carboxy-terminal hydrolase L1 (PGP 9.5)
(Uchl1)
AB025313 8.2 x KO: Gracile axonal dystrophy mouse, alters Parkinson's
risk
Fatty acid binding protein 7, brain (Fabp7) NM_021272 5.9 x x Expressed in enteric glia
Mab-21-like 1 (C. elegans) (Mab21l1) AW047968 5.1* Essential for eye development
Pancreatic lipase related protein 2 (Pnliprp2) M30687 4.3 x x Lipase expressed in pancreas, enterocytes and paneth cells
Profilin 2 (Pfn2) AW122536 3.0 Regulates actin polymerization
Sialyltransferase 8(alpha-2,8-sialyltransferase)C (Siat8c) X80502 3.0 Ganglioside synthetic enzyme
Follistatin-like 5 (Fstl5) AI850841 2.5*
Nel-like 2 homolog (chicken) (Nell2) AI838010 2.3* Important in hippocampus-dependent spatial learning
Vesicular membrane protein p24 (Vmp) D83206 2.4
ELAV-like 2 (Hu antigen B) (Elavl2) AW124188 2.4* RNA-binding protein
Kinesin family member 5C (Kif5c) AI842555 2.1* Microtubule motor, role in motor neuron maintenance
Each mRNAwas more abundant in WT than in aganglionic bowel (P<0.05). “FoldΔ” values were estimated by qRT-PCR as follows: FoldΔ=2−ΔΔCT, whereΔΔCT
is the difference in normalized crossing threshold for WT versus aganglionic bowel. “Fold Δ” values marked * were based on E14 gene microarray data. An “x” in
columns labeled E14 or P0 indicates that expression was confirmed by in situ hybridization. “o” indicates signal was not detected in the ENS region. A more extensive
searchable database of ENS gene expression is available at our website http://ensmutants.wustl.edu. This Microsoft Access gene expression database was created by
combining the new information in this manuscript with data from previously published literature including 1249 articles containing the words “enteric neuron”. In
addition, we examined in situ hybridization patterns in the www.genepaint.org database for 1275 genes expressed at E14.5. Of these in situ hybridization patterns
reviewed, 66 genes (5%) had prominent expression within the region of the ENS similar to that seen in Fig. 1. Thus, our gene enrichment strategy strongly selected for
genes with high expression levels in the region of the ENS. 16/66 of the genes identified in the www.genepaint.org database had already been described in the ENS
either in our studies for this manuscript or in the literature reviewed. The new database, which is the largest single public database of annotated ENS gene expression,
currently contains 319 entries, is annotated by gene function and chromosomal localization, but does not attempt to extensively reference each of the 319 genes. This
database will be maintained and updated on our website.
a Gene symbol is used for genes with long names. Full names are: Proprotein convertase subtilisin/kexin type 1 inhibitor (Pcsk1n); Serine (or cysteine) proteinase
inhibitor, clade E, member 2 (Serpine 2); and Transmembrane protein with EGF-like and two follistatin-like domains 2 (Tmeff2); Nuclear receptor subfamily 0,
group B, member 1 (Nr0b1); Ubiquitin carboxy-terminal hydrolase L1 (PGP 9.5, Uchl1); Sialyltransferase 8 (alpha-2,8-sialyltransferase)C (Siat8c).
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at E14 (Fig. 1). For several additional genes (Pcsk1n, Fgf13,
Ncam2, Cdh2, Dlx2, Nsg2, Dcx, Crmp1), expression isFig. 1. In situ hybridization. (A) Small bowel in situ hybridization at E14 and P0. Imag
genes indicated above each pair of images. Most of these genes are prominently expre
A few genes (Neurod1, Tmeff2, Erdr1) are expressed more broadly in the gut wall in
Images are shown for genes expressed at higher levels in WT than in aganglionic sm
aganglionic bowel as determined by qRT-PCR varies from 168.9-fold for Syt1 to 1.
higher expression in WT than in Ret−/− bowel based on microarray analysis. (A–C)
lumen. Arrowheads indicate the intestinal epithelium for the few genes with prominreported in the ENS at E14.5 at www.genepaint.org or in
published literature (Inagaki et al., 2000). Finally, to determine
whether small “fold change” values were likely to representes were obtained from cross-sections of the bowel hybridized with probes for the
ssed in the outer gut wall in the region of the developing enteric nervous system.
cluding in the intestinal epithelium. (B) Small bowel in situ hybridization at P0.
all bowel. (A, B) For these genes, “fold change” in expression between WT and
9-fold for Dlx6. (C) In situ hybridization at E14 for genes with 1.2- to 1.6-fold
In each image, arrows point to the region of the ENS. “L” indicates the bowel
ent epithelial expression. Scale bar=40 μm.
Fig. 1 (continued ).
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genes with 1.2- to 1.6-fold higher levels in WT than in Ret−/−
E14 bowel based on microarray analysis. For six of these seven
genes, prominent ENS expression was seen, but expressionFig. 2. Sox2 is expressed in ENS precursors at P0. Panel A shows in situ
hybridization for Sox2 at P0. There is prominent expression in the area of the
ENS (arrows) and also in the intestinal epithelium (arrowhead). Panel B shows
immunohistochemistry for Sox2 (orange) andRet (green). This analysis confirms
expression of Sox2 in the nucleus of Ret+ cells. Arrows point to Ret+ cytoplasmic
staining in the ENS. Arrowheads point to Sox2+ nuclei in the same cells. Scale
bar=50 μm.was also detected in other cells of the bowel wall (Fig. 1C).
Together, these data provide an extensive set of ENS
biomarkers whose function merits additional evaluation. We
have initiated functional studies for a few of the identified
genes.
α-N-catenin and protocadherin 15 are not required for ENS
development
Several genes essential for neuronal precursor migration
within the central nervous system (CNS) were found in the
developing ENS by in situ hybridization including Double-
cortin (des Portes et al., 1998), Ncam1 (Rolf et al., 2002), N-
Cadherin (Barami et al., 1994), α-N-catenin (Park et al.,
2002a) and Mapt (tau) (Takei et al., 2000). α-N-catenin
deficiency, for example, causes cerebellar and hippocampal
neuronal migration defects (Park et al., 2002a), but function
in the ENS was not known. To determine whether ENS
precursor migration was abnormal in α-N-catenin−/− mice, we
examined the ENS by whole-mount acetylcholinesterase and
Table 2
Genes with higher abundance in aganglionic bowel than innervated bowel
Gene name Accession # Fold Δ
Secreted phosphoprotein 1 (Minopontin, osteopontin) X13986 6.6
Kininogen NM_023125 4.2
Serum albumin with line-1 repeat X13060 4.0
Perinatal skeletal muscle myosin heavy chain M12289 3.5
Epiregulin AV231492 3.3
Cystic fibrosis transmembrane conductance regulator X72694 3.2
Alpha 2-Heremans-Schmid-glycoprotein AF025821 2.6
Islet amyloid polypeptide M25389 2.4
Anterior restricted homeobox protein (Rpx) U40720 2.3
Fold change values were determined by qRT-PCR and based on standard
dilution curves. P<0.05 for each gene.
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visualization of the myenteric and submucosal plexus
compared to sectioning and demonstrate clearly whether the
distal bowel is aganglionic or hypoganglionic. These staining
methods also demonstrate the organization of enteric ganglia
and their fibers so that significant changes in ENS structure
would be apparent. Note, however, that although both
acetylcholinesterase and NADPH diaphorase methods stain
major populations of enteric neurons and provide a good
screening approach to identify significant defects in ENS
structure, subtle changes in ENS structure or function may be
missed with these techniques. Nonetheless, no obvious intestinal
aganglionosis or hypoganglionosis was found, suggesting that
ENS precursor migration does not depend on α-N-catenin−/−
(Supplementary Fig. 1A and at http://ensmutants.wustl.edu).
ENS plexus organization also appeared normal in α-N-catenin−/−
mice.
Several other genes identified in the developing ENS have
roles in CNS axon growth, axon pathfinding and synaptic
plasticity including protocadherins (Frank and Kemler, 2002),
cadherins (Huntley, 2002), proteases (Parmar et al., 2002),
Crmp2 (Inagaki et al., 2001), Gap43 (Donovan et al., 2002) and
stathmin proteins (Liedtke et al., 2002). Their role in ENS
development has not yet been explored. Analysis of ENS
structure in protocadherin 15 deficient mice using the whole-
mount staining methods described above also failed to reveal an
obvious defect in ENS structure (Supplementary Fig. 1B and at
http://ensmutants.wustl.edu).
Abnormal epithelial gene expression in Ret−/− mice
While pursuing the studies above, we noticed that some
genes (Doublecortin, Erdr-1, Cadps, Tmeff2 and NeuroD1) are
expressed in both the ENS and other cells within the bowel.
Since several of these genes were identified based on markedlyFig. 3. Intestinal epithelial gene expression is abnormal in Ret−/−mice. (A, D) In situ
WT mucosa (arrowhead) and detectable expression in the region of the ENS (arr
significantly reduced expression in the mucosa and gut wall. (B, C, E, F) In contrast t
in WT littermates. Although epiregulin was detected in the ENS region (arrow) a
epiregulin expression (arrowheads) occurs in the epithelium of Ret−/− (E) compar
higher in Ret−/− than in WT intestinal epithelium. These findings were confirmed inincreased expression in WT compared to aganglionic bowel, we
hypothesized that gene expression in the intestinal epithelium
might also be abnormal in Ret mutant mice despite the absence
of detectable Ret expression within the intestinal epithelium.
We therefore used in situ hybridization to examine the
expression of one of these genes (Erythroid differentiation
regulator 1, Erdr1) in WT and aganglionic newborn bowel.
Although in situ hybridization is not as reliable as qRT-PCR for
quantitative analysis of gene expression, these studies clearly
demonstrated that the prominent Erdr1 expression in the
intestinal epithelium and other cells of the bowel wall was
reduced in Ret−/− mice compared to WT animals (Fig. 3A).
To find additional evidence of abnormal intestinal epithelial
gene expression in Ret−/− mice, we reviewed our GeneChip
data sets to identify genes expressed at higher levels in the
aganglionic bowel than in the WT bowel. Follow up qRT-PCR
studies confirmed that mRNA levels for 9 genes (Table 2) were
≥2-fold higher in P0 Ret−/− compared to WT intestine. These
genes include the cystic fibrosis transmembrane regulator (an
intestinal epithelial chloride channel implicated in control of
intestinal epithelial permeability and electrolyte transport)hybridization in P0 mouse small bowel demonstrates intense Erdr1 expression in
ow). In Ret−/− mice, there is no expression of Erdr1 in the ENS region and
o Erdr1, expression of osteopontin and epiregulin was higher in Ret−/−mice than
nd at low levels in the epithelium (arrowhead) of P0 WT mice (B), increased
ed to WT mice. (C, F) Osteopontin epithelial expression (arrowheads) is also
three independent experiments. Scale bar=40 μm.
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protein that reduces intestinal susceptibility to colitis (Lee et al.,
2004)) and osteopontin (a protein that contributes to and is a
marker for colon cancer tumor progression) (Agrawal et al.,
2003; Irby et al., 2004). In situ hybridization studies of epire-
gulin and osteopontin mRNAs confirmed prominent expression
outside of the ENS and increased epithelial expression in Ret−/−
mice compared to WT littermates (Figs. 3B, C, E, F). These
results provide strong evidence that intestinal epithelial gene
expression is abnormal in Ret−/− mice.
Synaptic function and ENS development
Many of the identified genes are important for synaptic
function including the SNARE complex proteins Snap25,
Cadps and Snap91. All of these genes are expressed in the ENS
at both P0 and E14. Although expression at P0 was expected to
allow the ENS to function, expression at E14 suggested theFig. 4. Botulinum toxin A or Tetanus toxin treatment slows neural crest-derived prec
incubated in organ culture for 50 h with Botulinum toxin A (BoNT/A) (B), Tetanus
using TuJ1 or Ret antibodies. Images show TuJ1-stained cells in the colon, but the
immunohistochemistry. The white line at the right side of the image corresponds to
neurons grown at low density under control conditions (D) or with BoNT/A (E)
immunohistochemistry. (G) Quantitative analysis of the percentage of the colon inn
migration into the distal bowel (*P<0.001). (E) Quantitative analysis of mean neurit
conditions, with BoNT/A or with TeNT, demonstrates that BoNT/A and TeNT redupossibility that these genes might play essential roles in ENS
development. To test the hypothesis that SNARE-dependent
vesicle fusion supports normal ENS development, E11.5 gut
explants were maintained in culture for 50 h with or without
Botulinum toxin A (BoNT/A) to cleave the t-SNARE Snap25
(Blasi et al., 1993; Breidenbach and Brunger, 2004; Chen and
Barbieri, 2006; Gerona et al., 2000) or Tetanus toxin (TeNT) to
cleave the v-SNARE Vamp/synaptobrevin (Rossetto et al.,
2001; Sakaba et al., 2005; Schiavo et al., 1992). These
Clostridial toxins are highly specific proteases that cleave and
inactivate their targets to block their function and inhibit
synaptic activity. At the start of these culture experiments,
enteric neural-crest-derived cells, which migrate in a rostrocau-
dal direction through the gut wall, had just reached the ileocecal
junction. During the time in culture, ENS precursors colonize
the majority of the colon under control conditions (90±3%,
n=7 explants). In contrast, both BoNT/A and TeNT treatments
slowed neural crest migration through the colon (Figs. 4A–C,ursor migration into the colon and reduces neurite length. E11.5 mouse gut was
toxin (TeNT) (C) or no added factor (A) before immunohistochemical staining
extent of neural crest precursor migration was similar with either Ret or TuJ1
the end of the colon. (D–F) Neurite length was measured in developing enteric
or TeNT (F) for 48 h. Cell bodies and neurites were visualized with TuJ1
ervated demonstrates that both BoNT/A and TeNT treatment slow neural crest
e length for the longest TuJ1+ neurite after culturing cells for 48 h under control
ce neurite length (*P<0.001). Scale bar=50 μm. Ce=cecum.
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respectively (n=4 BoNT/A and n=9 TeNT-treated explants;
P<0.006 versus control for each experimental group). When
both toxins were used together, there was no statistically
significant additive effect compared to either toxin alone
(66±3% colon innervation, n=5; P>0.05 compared to
either single toxin), suggesting that the individual toxins
fairly completely blocked SNARE-mediated vesicle fusion.
These experiments demonstrate novel and previously unsus-
pected roles for Snap25 and Vamp in ENS precursor migration.
Since both cell migration and neurite extension require the
addition of membrane to the leading edge of the cell or neurite,
we next investigated whether BoNT/A or TeNT treatment
influenced neurite growth in cultured ENS precursors. Cultures
of dissociated E12.5 small intestine including ENS precursors
were grown in GDNF containing media in the presence or
absence of BoNT/A or TeNT for 48 h. The length of the longest
neurite was measured (Figs. 4D–F, H). These studies demon-
strated a significant reduction in neurite length after both BoNT/
A and TeNT treatment (Fig. 4H, control=186±7 μm, BoNT/
A=127±4 μm, TeNT=116±4 μm, P<0.001 versus control for
each experimental group; n>155 neurites measured in each
group). Thus, SNARE function appears to be important for both
neurite growth and migration of ENS precursors.
To be certain that these results did not occur because of
changes in cell viability or proliferation under the culture
conditions, cell death of immunoselected ENS precursors was
measured by TUNEL histochemistry (n=3 separate experi-
ments) and cell proliferation was measured by H3P/Ret double
label immunohistochemistry (n=3 separate experiments). In
addition, for cells grown in isolated culture, all of the Ret
expressing cells in the well were counted. These studies
confirmed that under the experimental conditions BoNT/A and
TeNT did not alter cell death (%TUNEL positive/Ret+ cells:
control=1.3±0.5%, BoNT/A=1.3±0.7%, TeNT=1.3±0.4%,
n>6400 cells in each group), cell proliferation (H3PRet/Ret
expressing cells×100: control=20±2%, BoNT/A=20±2%,
TeNT=21±2%, n>1500 cells in each group) or the number
of Ret expressing cells/well (control =2216±90, BoNT/
A=2159±80, TeNT=2141±34, P>0.4 versus control). Thus,
inhibiting SNARE function by cleaving either of two different
proteins (Snap25 or Vamp/synaptobrevin) alters ENS precursor
migration and neurite extension without affecting cell survival
or proliferation.
Discussion
Although remarkable progress has been made defining the
molecular mechanisms of ENS development, the known genes
cannot adequately explain many aspects of ENS morphogen-
esis. In particular, mechanisms governing neurite extension,
axon pathfinding, neuronal precursor migration and neuronal
subtype identity remain poorly understood. Furthermore,
information about gene expression within the ENS is difficult
to find in the medical literature. To begin to address these
problems, we initiated differential gene expression and in situ
hybridization analyses to identify additional genes that mightregulate ENS morphogenesis. Our new data provide an
extensively annotated database of genes expressed in the
developing ENS. In addition, we created a more comprehensive
searchable electronic database by combining our new data with
other available information. This growing database (available at
http://ensmutants.wustl.edu/) contains 319 entries and repre-
sents the single most detailed source of information about gene
expression within the ENS currently available. By organizing
and annotating this information, we expect to spur novel
avenues of investigation and facilitate identification of genes
mutated in patients with Hirschsprung's disease or intestinal
pseudo-obstruction syndromes. Indeed, these studies led to our
own investigations into a-N-catenin, protocadherin 15, Snap25
and Vamp/synaptobrevin in the developing ENS. Many other
genes expressed in the ENS also deserve additional investiga-
tion. For example, Tmeff1 (www.genepaint.org), Edg2 (Segura
et al., 2004) and Ccr9 were identified by our studies and
extensive literature review as genes expressed in the ENS that
map to previously described Hirschsprung's disease suscept-
ibility loci at 9q31 (Bolk et al., 2000) and 3p21 (Gabriel et al.,
2002). The gene doublecortin may also deserve additional
evaluation since, as an X-linked gene required for cortical
neuron precursor migration, doublecortin could modify Hirsch-
sprung's disease penetrance and contribute to the 4:1 male/
female ratio in Hirschsprung's disease.
Transcription factors and ENS development
A small number of transcription factors are currently known
to influence ENS development (Phox2b, Mash1, Sox10, Pax3,
Tlx2 and Sox8) (Blaugrund et al., 1996; Lang et al., 2000;
Maka et al., 2005; Pattyn et al., 1999; Shirasawa et al., 1997;
Southard-Smith et al., 1999). Our studies identified seven
additional transcription factors expressed within the region of
the bowel containing the ENS (Dlx1, Dlx2, Dlx6, Myt1, Egr1,
Neurod1 and Sox2). Dlx2 had previously been demonstrated
in E12.5 mouse ENS and Dlx2 mutant mice have reduced
intestinal peristalsis (Qiu et al., 1995). In contrast, Sox2 is
important for maintaining CNS neural stem cells (Graham et al.,
2003) but is turned off when neural crest is specified and had
not been previously described in the ENS. Because transcription
factor expression critically determines neuronal subtype identity
in other regions of the nervous system, we anticipate that many
other transcriptional regulators will be required to establish all
of the distinct neuronal subtypes essential for normal ENS
function. Nonetheless, these new data more than double the
number of transcription factors previously known to be
expressed within the ENS and suggest new directions for
investigation into ENS morphogenesis.
Ret signaling and epithelial gene expression
Since Ret is not expressed in intestinal epithelium, we were
surprised to find altered intestinal epithelial gene expression in
Ret−/− mice. Indeed, some genes with abnormal epithelial
expression critically influence intestinal epithelial function.
This could in part explain the development of intestinal
269B.P.S. Vohra et al. / Developmental Biology 298 (2006) 259–271inflammation when the ENS is damaged (Bush et al., 1998).
While these data suggest the possibility that normal intestinal
epithelial development requires the ENS, additional studies will
be needed to exclude other possibilities.
Differential gene expression studies led to the identification of
novel roles for SNARE proteins in ENS development
In our analysis of 217 genes by qRT-PCR, only a few
mRNAs were at least 100-fold more abundant in WT than
aganglionic bowel (Ret, Phox2b and Mash1, Synaptotagmin 1,
Reticulon 1 and Erythroid differentiation regulator (Erdr1)).
Ret, Phox2b and Mash1 are already known to play critical roles
in ENS development, suggesting that the other highly
differentially expressed genes might also be essential for ENS
development or function.
Synaptotagmin 1 is a calcium sensor important for fast
neurotransmitter release at synapses by accelerating SNARE-
dependent membrane fusion (Yoshihara and Montana, 2004).
Reticulon 1 also binds to SNARE proteins and is implicated
in vesicle trafficking including regulated exocytosis (Steiner et
al., 2004). Remarkably, many other genes important for
synaptic function were also expressed in the ENS at both P0
and E14. For example, Snap25 is essential for evoked synaptic
transmission, but not for CNS neuronal process growth in vivo
(Molnar et al., 2002; Washbourne et al., 2002). Cadps is also
essential for calcium stimulated exocytosis (Grishanin et al.,
2004) while Snap91 is found in the presynaptic terminals and
promotes endocytosis (Morgan et al., 1999). These observations
suggested that regulated transmitter release or SNARE-
mediated vesicle fusion is important for ENS development
long before enteric neurons are required for intestinal motility.
Our new data demonstrating dramatic effects on ENS precursor
migration and neurite extension by inhibiting Snap25 or Vamp
support this hypothesis.
These data add to a recent, but growing literature implicating
both vesicle fusion and synaptic function in neuronal precursor
migration, differentiation and the establishment of an inter-
connected network of neurons. 5-HT2B receptor activation, for
example, promotes differentiation of fetal enteric neurons in
vitro (Fiorica-Howells et al., 2000), and synaptic activity
influences synapse development (Murphy, 2003) and dendritic
morphology (Wong and Ghosh, 2002) in other regions of the
nervous system. These results are also consistent with the
recent observation that SNARE function is required for the
migration of CHO-K1 and MDCK cells (Proux-Gillardeaux et
al., 2005; Tayeb et al., 2005) and that nitric oxide and cyclic
nucleotides regulate ENS precursor migration in insect
embryos (Haase and Bicker, 2003). Furthermore, neurotrans-
mitters have been implicated in neuronal precursor migration in
other regions of the embryo including effects of PACAP
(pituitary adenylate cyclase-activating peptide) (Falluel-Morel
et al., 2005), glutamate (Kim et al., 2005) and acetylcholine
(Fucile et al., 2004) on cerebellar granule cells, GABA
(gamma-aminobutyric acid) in the cerebral cortex (Bolteus
and Bordey, 2004; Lopez-Bendito et al., 2003) and serotonin in
GnRH (gonadotropin releasing hormone) producing neurons(Giacobini et al., 2004; Pronina et al., 2003). Together, these
data suggest that SNARE-dependent exocytosis is important for
ENS precursor migration and neurite extension. Determining
whether these SNARE proteins are needed for release of
specific neurotransmitters that secondarily affect ENS precursor
migration and neurite extension will require additional
investigation.
Overall, these findings provide many new avenues for
investigating ENS development by identifying a number of
growth factors, kinases, cell adhesion molecules and transcrip-
tion factors not previously known to be expressed within the
ENS. Furthermore, we have demonstrated that blocking Snap25
or Vamp reduces neural crest-derived precursor migration into
the distal bowel and decreases neurite extension in cultured
ENS precursors. The function of many other genes newly
identified as expressed in the ENS can be examined further in
vivo using mutant mice and efficiently pursued ex vivo using
ENS precursors in primary culture. By more broadly investigat-
ing genes that are important for ENS structure and function, we
may identify additional Hirschsprung's disease modifiers or
genes that result in human dysmotility syndromes.
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